Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Wh ...

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.383
https://www.valueinhealthjournal.com/article/S1098-3015(15)02459-6/fulltext
Title : Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Wh ...
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02459-6&doi=10.1016/j.jval.2015.09.383
First page : A842
Section Title : Research Podium Presentations - Session 1
Open access? : No
Section Order : 2604
Categories :
Tags :
Regions :
ViH Article Tags :